2013
DOI: 10.1016/j.biomaterials.2013.01.070
|View full text |Cite
|
Sign up to set email alerts
|

A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MR bimodal imagings and simultaneous drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

8
129
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 171 publications
(138 citation statements)
references
References 59 publications
8
129
0
1
Order By: Relevance
“…13C). 18 By culturing mouse fibroblastic cell lines and human cervical cancer cell lines in vitro, the authors showed enhanced doxorubicin delivery efficiency with LDH-Gd@Au compared with free doxorubicin (Fig. 13D).…”
Section: Metal Nanoparticle Dot-coated Ldhmentioning
confidence: 95%
See 1 more Smart Citation
“…13C). 18 By culturing mouse fibroblastic cell lines and human cervical cancer cell lines in vitro, the authors showed enhanced doxorubicin delivery efficiency with LDH-Gd@Au compared with free doxorubicin (Fig. 13D).…”
Section: Metal Nanoparticle Dot-coated Ldhmentioning
confidence: 95%
“…13D). 18 Meanwhile, thanks to the component of Gd 3+ and Au, the LDH-Gd@Au nanocomposite acted efficiently as a dual-functional contrast agent for magnetic resonance imaging and X-ray computed tomography imaging in a tumour-bearing mice model (Fig. 13E).…”
Section: Metal Nanoparticle Dot-coated Ldhmentioning
confidence: 98%
“…Riaz and Ashaf [85] have given a short review of recent research into the intercalation and delivery of anti-cancer drugs using LDHs. To date, LDHs have been utilized as nanocarriers for many anti-cancer drugs, such as folinic acid [48], methotrexate [48,50,86,87,88,89,90,91,92,93], 5-flourouracil [94,95,96,97] and doxifluridine [17], comptothecin [98,99,100], K 7 [PTiW 10 O 40 ]·6H 2 O [101], podophyllotoxin [102], and doxorubicin [103]. …”
Section: Drug–ldh Ddsmentioning
confidence: 99%
“…Shi et al [103] developed a Gd 3+ ions (magnetic resonance imaging (MRI) contrast agent) doped LDH/Au (computed tomography (CT) contrast agent) nanocomposite as both a drug carrier and a diagnostic agent. The LDH–Gd/Au nanocomposite have a high surface area (112.9 m 2 ·g −1 ), and thus high loading (264 mg (DOX)/g carrier) of the non-anionic anti-cancer drug doxorubicin by hydrogen bonding interaction, and the loaded DOX shows an interesting pH-responsive release, which is favorable for avoiding quick drug release in neutral blood system but promoting drug release at acidic tumor sites or within cells.…”
Section: Drug–ldh Ddsmentioning
confidence: 99%
“…In detail, owing to lack of sufficient understanding and rational cost-to-benefit analysis for each imaging approach, previous organizations of different imaging modalities are usually arbitrary, [13][14][15] e.g., Liu et al prepared multifunctional NaYF 4 :Yb, Er@mSiO 2 @Fe 3 O 4 -PEG nanoparticles for UCL/MR bioimaging, 15 but SiO 2 coating impeded light transmission and resulted in reduced fluorescence intensity in comparison to free UCNP nanoparticles, 16 In this report, with in-depth understanding of each operation principle, ultrasound, CT and MR are selected to acquire the complete information of caners via exerting their personal advantages. 18,19 Differing from the previous design strategy of CAs, namely simple assembly of building blocks, a novel design strategy, marriage of structure and composition designs has been developed. Moreover, a sequential self-reduction reaction (SSR) synthetic approach has been well established to fabricate a biocompatible US&MR&CT 'all in one' trimodal imaging probe …”
mentioning
confidence: 99%